MyFinsight
Home
About
Contact
Back
Income Statement
CRISPR Therapeutics AG (CRSP)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$208,643K
Foreign currency
translation adjustment
$80K
Net loss
-$208,549K
Unrealized (loss) gain on
marketable securities
-$174K
Other income, net
$22,067K
Net loss before
income taxes
-$207,257K
Provision for income taxes
$1,292K
Total other income,
net
$22,067K
Grant
$892K
Loss from operations
-$229,324K
Total revenue
$892K
Total operating
expenses
$230,216K
Acquired in-process
research and development
$96,253K
Collaboration expense, net
$45,153K
General and
administrative
$18,916K
Research and development
$69,894K
Back